CCL17 and neoplasm: In this study, we found that the TMB values in the CCL17 low-expression group were significantly higher than those in the CCL17 high-expression group (p < 0.001), suggesting that the degree of somatic mutation is higher and the increased tumor burden on the organism may be relatively more pronounced in the CCL17 low-expression group.